Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Posaconazole

Posaconazole

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Posaconazole

21 trials tracked of Posaconazole: 9 in phase 3 or 4 and 1 with published results. The most-cited published study has 273 citations.

21Trials tracked
9Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3 Phase 3 6 Phase 2 5 Phase 1 4 Other / NA 3
  1. Phase 3 A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) Completed · 273 cited
  2. Phase 4 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Completed
  3. Phase 4 Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients Completed
  4. Phase 4 Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) Completed
  5. Phase 3 Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) Completed
  6. Phase 3 POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Completed
Show 15 more trials
  1. Phase 3 Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551) Completed
  2. Phase 3 Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) Completed
  3. Phase 3 Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED) Completed
  4. Phase 2 A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) Completed
  5. Phase 2 Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Completed
  6. Phase 2 Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients Completed
  7. Phase 2 Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia Completed
  8. Phase 2 A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267) Completed
  9. Phase 1 A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers Completed
  10. Phase 1 Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) Completed
  11. Phase 1 Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) Completed
  12. Phase 1 Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) Completed
  13. N/A Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641) Completed
  14. N/A Effect of Inflammation on Pharmacokinetics of Posaconazole Completed
  15. N/A Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.